dc.contributor.author | Yilmaz, Deniz Demir | |
dc.contributor.author | Musellim, Benan | |
dc.contributor.author | BÖREKÇİ, Şermin | |
dc.date.accessioned | 2021-12-10T12:49:58Z | |
dc.date.available | 2021-12-10T12:49:58Z | |
dc.identifier.citation | Yilmaz D. D. , BÖREKÇİ Ş., Musellim B., "Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study", CLINICAL RHEUMATOLOGY, cilt.40, ss.4071-4079, 2021 | |
dc.identifier.issn | 0770-3198 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_dae75552-7266-4d6d-93b7-810dfe2ea373 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/174791 | |
dc.identifier.uri | https://doi.org/10.1007/s10067-021-05785-6 | |
dc.description.abstract | Objectives To compare the effectiveness of cyclophosphamide and rituximab in the treatment of patients with systemic sclerosis with pulmonary involvement (SSc-ILD). | |
dc.language.iso | eng | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Rheumatology | |
dc.subject | Health Sciences | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study | |
dc.type | Makale | |
dc.relation.journal | CLINICAL RHEUMATOLOGY | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , , | |
dc.identifier.volume | 40 | |
dc.identifier.startpage | 4071 | |
dc.identifier.endpage | 4079 | |
dc.contributor.firstauthorID | 2638063 | |